Core C: Translational Research
核心 C:转化研究
基本信息
- 批准号:8203930
- 负责人:
- 金额:$ 17.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AntioxidantsBiopsyBloodBullaClinicClinicalClinical DataClinical SciencesClinical TrialsClinical Trials DesignCollaborationsCommunitiesComprehensive Cancer CenterConduct Clinical TrialsCore FacilityDataDermatologicDermatologyDevelopmentDevelopmental Therapeutics ProgramDevicesDiseaseDoseEducationEnsureEquipmentFosteringFoundationsGuidelinesHospitalsHousingHumanImageIn VitroInformed ConsentInstitutionInstitutional Review BoardsInterventionInvestigationLaboratoriesLaboratory StudyLeadLinkMedical centerMentorsMonitorNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNursesOutcomes ResearchPatientsPhotochemotherapyPhysiciansPreparationProceduresProtocols documentationPunch BiopsyRecordsRecruitment ActivityResearchResearch PersonnelResourcesSafetyScheduleScienceServicesSimulateSkinSolar EnergySpecimenStructureSuctionSunscreening AgentsSystemTechnologyTestingTissuesTopical agentTranslational ResearchUV Radiation ExposureUltrasonographyUnited States Department of Veterans AffairsUniversitiesUniversity HospitalsWaterbench to bedsidecohortcostcost effectivedesignhuman studyhuman subjecthuman tissuein vivointerestmeetingsmembernew technologynovelresearch studyskin disordertranslational approachvolunteer
项目摘要
Translational Research Core Facility is specifically designed to promote and facilitate involvement of human
subjects for skin and skin disease-related research. It aims to derive maximum information from human
studies by providing a resource that integrates organization of patient cohorts with mechanistic studies using
tissues, outcomes research, clinical trials, and laboratory investigation. This Core is structured to meet the
SDRC membership's needs for human tissue, (e.g. punch biopsies, keratomes, suction blisters), to provide
the SDRC membership with enabling technologies for human skin investigation (e.g. simulated solar
radiation, chromometer, transepidermal water loss device), and to lead in the development of novel
technologies that will benefit SDRC membership (e.g. imaging system for photodynamic therapy, skin
ultrasound, in vivo confocal imaging). It aims to provide a cost-efficient, central resource to identify and
recruit volunteers to participate in human in vivo studies and/or donate blood or skin biopsy tissue for ex
vivo/in vitro investigations. The utilization of core functions is expanded mainly by active interactions with
physicians who refer patients and with other investigators through the Clinical and Translational Science
Collaborative, Case Comprehensive Cancer Center, Center for Aids Research, and other research foci
within the University. A research assistant coordinates these services. The core also aims to provide overall
management of clinical trials of novel therapies brought from the laboratory to the bedside with emphasis on
providing optimal translational and clinical data. A group with expertise in general trial design, regulatory and
compliance aspects of human studies, assemble to efficiently direct or conduct high quality studies that arise
through interaction with various investigators interested in skin research. Additionally, interactions between
clinical and laboratory researchers are fostered to insert adjunctive laboratory studies to clarify mechanisms
of action of therapies and pathomechanisms of disease. The core also provides support, mentoring and
education regarding human research compliance, to members of the SDRC.
翻译研究核心设施是专门设计来促进和促进人类的参与
皮肤和皮肤病相关研究的对象。它旨在从人类获取最大限度的信息
通过提供一种资源,将患者队列的组织与使用
组织、结果研究、临床试验和实验室研究。该核心的结构是为了满足
SDRC成员对人体组织的需求(例如打孔活检、角膜刀、吸引水泡),以提供
SDRC成员具有用于人体皮肤研究的使能技术(例如,模拟太阳能
辐射,色度计,经表皮水分流失装置),并导致在开发新的
有利于SDRC成员资格的技术(例如,用于光动力治疗的成像系统,皮肤
超声、体内共焦成像)。它旨在提供一个具有成本效益的中央资源,以确定和
招募志愿者参与人体体内研究和/或捐献血液或皮肤活检组织,
体内/体外研究。核心职能的利用主要是通过与
通过临床和转化科学转介患者和其他研究者的医生
合作,病例综合癌症中心,艾滋病研究中心和其他研究中心
在大学里。一名研究助理负责协调这些服务。核心还旨在提供总体
管理从实验室到床边的新疗法临床试验,重点是
提供最佳的翻译和临床数据。一个在一般试验设计、监管和
人类研究的合规性方面,组装以有效指导或进行高质量的研究,
通过与对皮肤研究感兴趣的各种研究人员的互动。此外,
临床和实验室研究人员被鼓励插入连续的实验室研究,以阐明机制
治疗的作用和疾病的病理机制核心还提供支持、指导和
对SDRC成员进行有关人体研究合规性的教育。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELMA D BARON其他文献
ELMA D BARON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELMA D BARON', 18)}}的其他基金
Phase 1 Study of Pc 4 Photodynamic Therapy for Tx of Cutaneous T-Cell Lymphoma
Pc 4 光动力疗法治疗皮肤 T 细胞淋巴瘤 Tx 的一期研究
- 批准号:
8355580 - 财政年份:2012
- 资助金额:
$ 17.47万 - 项目类别:
Phase 1 Study of Pc 4 Photodynamic Therapy for Tx of Cutaneous T-Cell Lymphoma
Pc 4 光动力疗法治疗皮肤 T 细胞淋巴瘤 Tx 的一期研究
- 批准号:
8724218 - 财政年份:2012
- 资助金额:
$ 17.47万 - 项目类别:
Phase 1 Study of Pc 4 Photodynamic Therapy for Tx of Cutaneous T-Cell Lymphoma
Pc 4 光动力疗法治疗皮肤 T 细胞淋巴瘤 Tx 的一期研究
- 批准号:
8544193 - 财政年份:2012
- 资助金额:
$ 17.47万 - 项目类别:
Characterization of Cell Killing after Photodynamic Therapy with Pc4
Pc4 光动力治疗后细胞杀伤的表征
- 批准号:
7502416 - 财政年份:2007
- 资助金额:
$ 17.47万 - 项目类别:
相似海外基金
Optimizing blood biopsy in cancers with low mutation burden and high structural complexity
优化突变负荷低、结构复杂性高的癌症的血液活检
- 批准号:
10789700 - 财政年份:2023
- 资助金额:
$ 17.47万 - 项目类别:
L2M NSERC - A liquid biopsy blood test for breast cancer detection
L2M NSERC - 用于乳腺癌检测的液体活检血液测试
- 批准号:
576550-2022 - 财政年份:2022
- 资助金额:
$ 17.47万 - 项目类别:
Idea to Innovation
Liquid biopsy for Rhabdoid tumor by Exoxomal-microRNAs in blood and other body fluids
利用血液和其他体液中的 Exoxomal-microRNA 对横纹肌样瘤进行液体活检
- 批准号:
21K07778 - 财政年份:2021
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10634540 - 财政年份:2021
- 资助金额:
$ 17.47万 - 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10421266 - 财政年份:2021
- 资助金额:
$ 17.47万 - 项目类别:
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
利用犬自发癌优化血液活检的功效
- 批准号:
10844821 - 财政年份:2021
- 资助金额:
$ 17.47万 - 项目类别:
Implication search for peripheral blood circulation cancer cellsas a Liquid biopsy target
外周血循环癌细胞作为液体活检目标的意义研究
- 批准号:
21H03021 - 财政年份:2021
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Monitoring of residual and recurrence of cervical cancer after radiotherapy using blood liquid biopsy.
使用血液活检监测放疗后宫颈癌的残留和复发。
- 批准号:
20K08106 - 财政年份:2020
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a Novel Liquid Biopsy Technique for Colorectal Cancer Using MicroRNA Editing in Blood
利用血液中的 MicroRNA 编辑建立结直肠癌新型液体活检技术
- 批准号:
20K22848 - 财政年份:2020
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Prediction of colorectal cancer using liquid biopsy of the blood in surgically resected specimen
利用手术切除标本中血液的液体活检预测结直肠癌
- 批准号:
19K09127 - 财政年份:2019
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




